header logo image


Page 1,190«..1020..1,1891,1901,1911,192..1,2001,210..»

Rheumatoid Arthritis Condition Center – Health.com

July 9th, 2015 5:43 pm

WEEKLY NEWSLETTER

Free Pain Prevention Email Newsletter

Updates, news, special offers, and expert tips to stop aches and pains from interrupting your life.

Rheumatoid Arthritis Journey

By Maureen SalamonHealthDay Reporter THURSDAY, June 20 (HealthDay News) The common belief that rheumatoid arthritis patients dont benefit from knee replacement surgery as much as those with the more common osteoarthritis has been challenged by the findings from a pair of studies by New York City scientists. Researchers from the Hospital for Special Surgery also found, [...]

Eating lots of foods loaded with salt may do more than raise your blood pressure: Researchers report that it could also contribute to the development of autoimmune diseases, where the bodys immune system mistakenly mounts an attack upon some part of the body. Three new studies suggest salt may be a prime suspect in a wide range of autoimmune diseases, including multiple sclerosis (MS), psoriasis, rheumatoid arthritis and ankylosing spondylitis (arthritis of the spine).

TUESDAY, Feb. 5 (HealthDay News) Older women whove had regular exposure to sunlight may be less likely to develop rheumatoid arthritis, new findings indicate. This beneficial effect which is believed to be due to ultraviolet B (UV-B) in sunlight was only evident in older women. This may be because younger women are [...]

Genes specific to the X chromosome are among newly identified genes linked to rheumatoid arthritis and could help explain why women are more likely than men to develop the disease, researchers say. Women have two X chromosomes while men have an X and a Y chromosome.

WEDNESDAY, Nov. 28 (HealthDay News) Patients with rheumatoid arthritis are more likely to suffer hip dislocation after hip replacement surgery than those with osteoarthritis, a new study says. In addition, rheumatoid arthritis patients have a higher infection risk after total knee replacement than osteoarthritis patients, the study authors found. Rheumatoid arthritis, which is felt throughout the [...]

Read the original post:
Rheumatoid Arthritis Condition Center - Health.com

Read More...

What is Arthritis? (with pictures) – wiseGEEK

July 9th, 2015 5:43 pm

bagley79 Post 6

I broke my arm many years ago when I was skiing. I know I have arthritis in that arm because that area is often stiff and I don't have as much range of motion.

This arm really hurts on days that are cold and damp and I know it is from some type of degenerative arthritis in my joints where I had the break.

On another ski trip, I injured my knee and that knee is also the one that gives me troubles. All of my old injuries are coming back to haunt me with arthritis. I don't know why that seems to happen as you age, but those are the areas where I have the most pain and stiffness.

I don't have any type of rheumatoid arthritis, but have noticed a significant difference in my joints as I have gotten older.

Now I think twice about getting down on the floor for something because it will take me longer to get up. I have also noticed a difference when I am gardening.

It is not as easy to get up and down and do all the bending that is required when you garden. At the end of a long day, my joints are stiff and sore. I have found that soaking in a tub of hot water gives me some relief.

I have joined that group of people who are over 50, and know what it feels like to have joints that are stiff, sore and don't work the way they used to.

I find it interesting that even dinosaurs had problems with arthritis. This is something that is also very common in dogs. Every dog I have ever owned that has made it to old age, has had some form of arthritis.

The larger dogs seems to be affected with this more than the smaller dogs. I had a golden retriever who started having problems with arthritis when she was about 8 years old. It was harder for her to get up and move around.

Continued here:
What is Arthritis? (with pictures) - wiseGEEK

Read More...

Rheumatoid Arthritis (RA)

July 9th, 2015 5:43 pm

Rheumatoid arthritis is an autoimmune disease in which your body starts destroying itself. It can be a devastating disease that can certainly destroy your health.

Of course, the U.S. "health" care system has evolved to one that focuses on using drugs and surgery as its primary treatment tool. This works exceptionally well for some diseases -- like acute trauma -- but for other diseases, especially autoimmune diseases like rheumatoid arthritis, it is an abysmal failure.

I have personally treated over 3,000 patients with rheumatoid arthritis in my practice, which is well more than 10 times the amount a typical family physician would treat in their entire career. So I have a fair amount of experience here.

The treatment protocol I used is available for all to review. It involves the following

Lifestyle Changes

Eliminating sugar and most grains

Having unprocessed, high-quality foods, organic and locally grown if possible

Eating your food as close to raw as possible

Getting plenty high-quality animal-based omega-3 fats, such as krill oil

Address Emotional Trauma

Read more:
Rheumatoid Arthritis (RA)

Read More...

Knee Arthritis – Diagnosis and Treatment of Wear and Tear

July 9th, 2015 5:43 pm

Arthritis is a common cause of knee pain. J. M. Horrillo / Getty Images

Updated December 20, 2014.

Written or reviewed by a board-certified physician. See About.com's Medical Review Board.

Arthritis of the knee joint is one of the most common causes of knee pain. There are different types of arthritis that can affect the knee joint, and the treatments may vary depending on the condition that is causing the symptoms.

Osteoarthritis is the most common type of knee arthritis. Also called wear-and-tear arthritis or degenerative joint disease, osteoarthritis is characterized by progressive wearing away of the cartilage in the joint. As the protective cartilage is worn away, bone is exposed, the knee becomes swollen and painful, and activities become increasingly painful.

Knee arthritis typically affects patients as they get older. Symptoms are more common in patients who are overweight, and weight loss tends to reduce the severity of pain associated with knee arthritis.

There is also a genetic component, meaning knee arthritis can be passed down within a family. Other factors that can contribute to developing knee arthritis include injuries to the knee, torn cartilage, and fractures to the bone around the joint.

Knee arthritis symptoms tend to gradually progress as the condition worsens, however, symptoms may suddenly worsen with minor injury or overuse. Some patients report long episodes of mild symptoms, with sudden changes that increase the severity of their symptoms. Often patients report good months and bad months, or symptoms that fluctuate with the weather. This is important to understand because comparing the symptoms of arthritis on one particular day may not accurately represent the overall progression of the condition. Since there is not a cure for arthritis, learning ways to slow the progression of arthritis is also important.

The most common symptoms of knee arthritis include:

BJ Cole and CD Harner "Degenerative arthritis of the knee in active patients: evaluation and management" J. Am. Acad. Ortho. Surg., Nov 1999; 7: 389 - 402.

Link:
Knee Arthritis - Diagnosis and Treatment of Wear and Tear

Read More...

Home Remedies for Arthritis Pain: Symptoms, Treatment …

July 9th, 2015 5:43 pm

Topic Contents:

advertisement

Arthritis is a progressive inflammatory condition caused when the soft muscles in the joints become inflamed, severely restricting the movement of the joint and causing a lot of pain and discomfort. In older people, who are most susceptible to this condition, arthritis is the leading cause of restriction of movement or immobility. Arthritis is a condition that we are all quite familiar with and even if you havent been afflicted with the condition it is most likely that you are acquainted with someone who is. Arthritis is a degenerative condition that affects the joints causing severe pain and greatly reducing mobility. In severe cases and if neglected the effects can be debilitating. Arthritis is typically associated with old age and although most prevalent among the aged it can affect almost anyone, but this it is uncommon among young adults and children. Arthritis may not be a life threatening condition but it is a dreaded condition because of the extent to which it affects your life. Simple tasks and routines that we normally take for granted can become quite a challenge. For example, arthritis in the hands, wrists or fingers can make working at the computer near impossible. While it can be quite debilitating it is not unmanageable. Arthritis can be managed and controlled to minimize its impact on your life. But to effectively control and treat the condition you need to be well informed and understand the condition.

The word 'arthritis' means 'inflammation of the joints'. It is derived from two Greek words: athron, meaning joints; and itis, meaning inflammation. It is, generally, a chronic disease process. Arthritis occurs in various forms, the most frequent being osteoarthritis and rheumatoid arthritis. Osteoarthritis is a degenerative joint disease which usually occurs in the older age-group. Rheumatoid arthritis is a serious disease which affects not only the joints of the fingers, wrists, hips, knees, and feet, but also the muscles, tendons and other tissues of the body.

There are a lot of different kinds of arthritis, categorized according to the extent of wear and tear in the joints and the cartilaginous tissues. Sometimes, the inflammation could be caused due to excessive wear and tear of the joints. However, the inflammation could also be caused due to autoimmune disorders. Such disorders, in which the immune system attacks the joints, are one of the leading causes of arthritis and rheumatism.

There are various types of arthritis but most forms of the condition do cause some amount of swelling and pain the joints, so if you do experience pain and stiffness in any of the joints in your body on a regular basis then it is possible that you may be suffering from arthritis. All of our bodily movements and our mobility or flexibility is dependent on the proper functioning of the joints. Swelling or inflammation of the joints, which is typical of most types of arthritis, can however cause the joints to get severely damaged over time. Some forms of arthritis can even cause problems in organs like the eyes or skin.

Osteoarthritis is one of the most common manifestations of arthritis and this usually develops as a result of aging or due to some injury. Some types of arthritis may also develop as a result of your immune system turning on your own body. The immune system which normally protects against infections may begin attacking your own bodys tissue in this type of arthritis, with rheumatoid arthritis being the most common. Although arthritis is by and large associated with old age or aging, the condition can also affect children. Juvenile rheumatoid arthritis is fortunately a very rare condition. At times arthritis may develop as a result of an infections spreading from one part of the body to the joint, and this is termed as infectious arthritis.

Arthritis may be a degenerative condition to which there is no permanent cure, but treatment can help to manage and control arthritis, reducing its effect on your everyday life. The main focus of arthritis treatment, whether with conventional treatment or with natural arthritis remedies is towards preventing further deterioration of the joints and to increase and preserve mobility, while restricting arthritis pain. Arthritis pain relief and management is best achieved through a combination of medical treatments and natural remedies or self care that could include specialized arthritis diet plans, lifestyle routines, and physiotherapy that may include specific exercises like yoga or pilates.

Arthritis in the hands and feet or hips can be particularly problematic during pregnancy. Women suffering from arthritis should give serious thought to a decision to get pregnant because of the risk of complications.

See the article here:
Home Remedies for Arthritis Pain: Symptoms, Treatment ...

Read More...

Stem Cell Transplant For Kidney Disease-Kidney Failure

July 8th, 2015 6:47 pm

We can say that Stem Cell Therapy is the most efficient treatment for people with kidney disease. Its application makes dialysis or kidney transplant is no longer the only choice. No matter which type of kidney disease you are suffering from, you are still expected to live a normal life as the damaged kidneys can be saved. Now follow us to learn more about Stem Cell Therapy.

Stem Cells are pluripotent cells with strong power of self-replicating and directional differentiation. They are original and immature cells and have the potential ability to regenerate various tissues and organs.

There are different classifications of stem cells according to different criteria. They can be divided into totipotent stem cells, pluripotent stem cells and unipotent stem cells according to their developmental potentiality; according to the developmental stage, they can be divided into embryonic stem cells and somatic stem cells.

Certain stem cells and immune cells will be injected into body to activate human body's self-healing capability, regulate and control the diseased cells, activate cell function, increase the number of normal cells, enhance cell activity, improve the quality of cells and recover cell normal physiological functions.

Stem cells can differentiate into renal intrinsic cells, renal parenchymal cells which can replace the dead and necrotic renal cells and tissues and activate regeneration of body's own cells. These new functional cells can help repair kidney damages and rebuild kidney functions.

Stem Cell Therapy has not been commonly used in every country. Some argue that it is immoral to collect embryonic stem cells from the embryos because embryos is one form of life. Some people worry that companies will provide funds for in vitro fertilization and artificial abortion to obtain more cell lines and they suggest more researches on adult stem cells and give up embryonic stem cell research.

Nowadays, in China, mesenchymal stem cells or umbilical cord blood stem cells are used to replace embryonic stem cells.

-Stem cells have very strong power of proliferation and differentiation and they can produce large number of new functional cells.

-No rejection reaction. Because stem cells are the original cells of the body, the surface antigen is not obvious enough to be recognized by antibody. So there is no rejection reaction after a Stem Cell Therapy.

-It has the convenience of easy separation, culture, amplification and purification and still has the characteristics of stem cells after several times proliferations.

Read the original here:
Stem Cell Transplant For Kidney Disease-Kidney Failure

Read More...

Stem Cell Research & Therapy | Full text | Safety and …

July 8th, 2015 6:47 pm

Abstract Introduction

Administration of mesenchymal stem cells (MSCs) has been shown to improve renal function in rodent models of chronic kidney disease (CKD), in part by reducing intrarenal inflammation and suppressing fibrosis. CKD in cats is characterized by tubulointerstitial inflammation and fibrosis, and thus treatment with MSCs might improve renal function and urinary markers of inflammation in this disease. Therefore, a series of pilot studies was conducted to assess the safety and efficacy of intravenous administration of allogeneic adipose-derived MSCs (aMSCs) in cats with naturally occurring CKD.

Cats enrolled in these studies received an intravenous infusion of allogeneic aMSCs every 2 weeks collected from healthy, young, specific pathogen-free cats. Cats in pilot study 1 (six cats) received 2 106 cryopreserved aMSCs per infusion, cats in pilot study 2 (five cats) received 4 106 cryopreserved aMSCs per infusion, and cats in pilot study 3 (five cats) received 4 106 aMSCs cultured from cryopreserved adipose. Serum biochemistry, complete blood count, urinalysis, urine protein, glomerular filtration rate, and urinary cytokine concentrations were monitored during the treatment period. Changes in clinical parameters were compared statistically by means of repeated measures analysis of variance (ANOVA) followed by Bonferronis correction.

Cats in pilot study 1 had few adverse effects from the aMSC infusions and there was a statistically significant decrease in serum creatinine concentrations during the study period, however the degree of decrease seems unlikely to be clinically relevant. Adverse effects of the aMSC infusion in cats in pilot study 2 included vomiting (2/5 cats) during infusion and increased respiratory rate and effort (4/5 cats). Cats in pilot study 3 did not experience any adverse side effects. Serum creatinine concentrations and glomerular filtration rates did not change significantly in cats in pilot studies 2 and 3.

Administration of cryopreserved aMSCs was associated with significant adverse effects and no discernible clinically relevant improvement in renal functional parameters. Administration of aMSCs cultured from cryopreserved adipose was not associated with adverse effects, but was also not associated with improvement in renal functional parameters.

Chronic kidney disease (CKD) is a common condition in elderly cats and is characterized by tubulointerstitial inflammation, tubular atrophy and interstitial fibrosis with subsequent progressive loss of renal function [1,2]. Currently there is no definitive therapy short of renal transplant to improve kidney function in cats with CKD. Therefore, novel and effective therapeutic options are highly desired for treating this disease in cats.

Recently, a number of studies have suggested the use of mesenchymal stem cells (MSCs) as a novel treatment option for management of CKD, based on encouraging data from rodent studies [3-7]. There have been several rationales advanced for the use of MSCs for treatment of CKD. Rodent studies have suggested that MSCs may incorporate into the renal parenchyma and give rise to new renal tubular cells, though the process appears to be relatively inefficient [8-17]. MSCs also exert potent anti-inflammatory and antifibrotic effects and may therefore indirectly improve renal function by reducing disease-associated inflammation and fibrosis through paracrine effects [3-7]. For example, MSCs have been shown to inhibit lymphocyte proliferation and cytokine production, suppress dendritic cell function, and suppress interferon (IFN) production by natural killer (NK) cells [18].

Since inflammation appears to be present at all stages of CKD in cats, the immunomodulatory actions of MSCs are appealing as an alternative means of suppressing intrarenal inflammation long term and with fewer side effects than with conventional anti-inflammatory drugs. In the majority of experimentally-induced CKD models investigated, MSC administration resulted in improved renal function, decreased intrarenal inflammation, and reduction of renal fibrosis [3-7]. Thus, MSC therapy may be an effective new approach to slow the progression of CKD and improve renal function.

Previous studies have demonstrated that cultured MSCs can be administered intravenously to rodents as well as to humans. However, in rodent models there is a significant risk of pulmonary thrombosis when high numbers of MSCs are rapidly administered intravenously [19]. Alternative routes of delivery have included injection via the renal artery, injection directly into the renal parenchyma, and injection into the renal subcapsular space [3-7]. One potential advantage of intravenous delivery compared to other routes may be the induction of renotropic paracrine effects following intravenous administration of MSCs [20].

Based on compelling results from rodent studies, we conducted a series of pilot studies to investigate the safety and potential efficacy of adipose-derived MSC (aMSC) therapy as a treatment for cats with naturally occurring CKD. These studies were designed to test the hypothesis that allogeneic cryopreserved aMSCs could be safely administered to cats with CKD and would result in improvement in kidney function. For this study, aMSCs were derived from allogeneic, healthy, specific pathogen-free (SPF) donor cats and cryopreserved, either as cells or adipose tissue, prior to intravenous administration to study cats. One primary study endpoint was to determine safety and potential adverse effects of repeated intravenous administration of cryopreserved aMSCs. The second major endpoint was to determine whether repeated MSC administrations were associated with improvement in renal function or urinary markers of intrarenal inflammation. These studies produced evidence of modest, but unlikely to be clinically significant, improvement in renal function but also showed evidence of significant adverse effects associated with intravenous administration of higher doses of cryopreserved aMSCs.

See more here:
Stem Cell Research & Therapy | Full text | Safety and ...

Read More...

"Latest Stem Cells News" – news from the world about stem …

July 8th, 2015 6:46 pm

Image via Wikipedia

Responsible in the past for unprecedented violence, eugenics is a major worry of Pope Benedict XVI, who yesterday spoke about how these deplorable practices present themselves today differently with the selection of embryos and the discrimination of the sick and disabled, resulting in a rejection of life in the name of an abstract ideal of health.

Receiving the participants of the conference called The new frontiers of genetics, which is taking place in the upcoming days at the Vatican, Ratzinger immediately clarified that all discrimination based on differences that are ascribed to real or assumed genetic factors is Read More

Gianvito Martino, the head of the Neurosciences division at the Institute of San Raffaele in Milan in a speech at Multiple Sclerosis Week, which took place from May 23-31, warned against trips of hope to clinics that promise effective treatments using stem cells.

According to Martino, who coordinated a Consensus Conference on last Tuesday in London on the neurodegenerative disease, where the guidelines for pre-clinical studies and clinical treatments with stem cells were defined, hundreds of Italian patients each year go on these trips due to cures that are promised. In the best-case scenario, these patients return in the Read More

Image via Wikipedia

A Swiss company present in Italy that collects and stores umbilical cord stem cells, about 10,000 Italian mothers by the end of the year will have deposited their childrens umbilical cord stem cells in foreign banks, double compared to 2007. They said, Just two years ago about 1,500 families decided to deposit their childrens umbilical cord stem cells in banks. In 2007, requests for this service tripled, reaching 5,000 and in 2008. There will be about 10,000 new cryostorages in order to make stem cells available in the future (illegal in Italy). Read More

Image via Wikipedia

Dozens of people who were blinded or otherwise suffered severe eye damage when they were splashed with caustic chemicals had their sight restored with transplants of their own stem cells a stunning success for the burgeoning cell-therapy field, Italian researchers reported Wednesday.

The treatment worked completely in 82 of 107 eyes and partially in 14 others, with benefits lasting up to a decade so far. One man whose eyes were severely damaged more than 60 years ago now has near-normal vision.

Continue reading here:
"Latest Stem Cells News" - news from the world about stem ...

Read More...

Regenerative Medicine Journals | Stem Cell Articles List

July 8th, 2015 6:46 pm

Journal of Regenerative Medicine Journal of Regenerative Medicine (JRGM) is a peer-reviewed scholarly journal and aims to publish the most complete and reliable source of information on the discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in all areas of stem cells and regenerative medicine and making them available online freelywithout any restrictions or any other subscriptions to researchers worldwide. Journal of Regenerative Medicine focuses on the topics include regenerative medicine therapies, stem cell applications, tissue engineering, gene and cell therapies, translational medicine and tissue regeneration. The Journal is using Editorial Manager System for quality in review process. Editorial Manager is an online manuscript submission, review and tracking system. Review processing is performed by the editorial board members ofJournal Regenerative Medicine or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process. Interested authors can submit manuscript through Online Submission System or Editorial Manager or send as an e-mail attachment to the Editorial Office ateditor.jrgm@scitechnol.com oreditor.jrgm@scitechnol.org Journal of Regenerative Medicine is organizing & supporting3rd International Conference on Tissue Science & Regenerative Medicine during September 24-26, 2014 Valencia, Spain with the theme ofBreakthrough Strategies for Tissue Engineering, Repair & Regeneration.

*Unofficial 2014 Impact Factor was established by dividing the number of articles published in 2012 and 2013 with the number of times they are cited in 2014 based on Google search and the Scholar Citation Index database. If X is the total number of articles published in 2012 and 2013, and Y is the number of times these articles were cited in indexed journals during 2014 than, impact factor = Y/X.

Heterogeneity of Stem Cells in Human Amniotic Fluid

Amniotic fluid contains a mixture of cells with capacity to differentiate into all germ layers. These cells are present in large numbers in midtrimester samples obtained for cytogenetic diagnosis, and have been identified by stem cell surface markers and transcription factors. We studied cultured samples from patients who had both direct cultures and matched cultures obtained 2 weeks later from the cytogenetics laboratory as well as patients with cytogenetics material only. Samples were cryogenically frozen, thawed, expanded in culture with excellent viability. There was considerable individual variation unrelated to gestational age or telomere length. Phenotype for embryonic markers was assessed by flow cytometry and by quantitative polymerase chain reaction. The most consistently present stem cell markers in substantial amounts were CD90, SSEA-4, & TRA-1-60. Cells with CD90, SSEA-4 & TRA-1-60 double and triple labeled also could be identified and subcultured, confirming the heterogeneity of the amniotic fluid stem cell population.

Patent Knowledge and Stem Cell Scientists

The knowledge economy is progressing at a rapid pace and increasingly relying on intangible assets as a form of recoupling its investments. Intangible assets include intellectual capital and intellectual property, with an emphasis on patents here. Due to the unawareness about intellectual property rights, researchers, very often, are flying blind unaware of opportunities and threats posed by patents to their research projects. Although, the business acumen of many (private and public) scientists has markedly increased in recent years, large numbers are still left outside the patent loop of opportunities and knowledge of obstacles to their research. Knowledge about patents carries important implications for all researchers and those responsible for science and technology policy making.

Platelet-Rich Plasma Therapies:In the Right Pathway to Find their Regulatory Niche

The Spanish Agency of Medicines and Medical Devices (AEMPS) has recently regulated the use of platelet-rich plasma (PRP), that is,patients own plasma enriched in platelets and therefore in proteins and growth factors, as a human use drug. It is the first time that one regulatory agency worldwide categorizes these types of therapeutic therapies. According to AEMPS, PRP approaches cannot be considered as an advanced-therapy medicinal product. PRPs are classified as non-industrial biological medicines, being subjected to a strict regulation in terms of production, validation, efficacy and safety.

Understanding Somatic (Adult)Stem Cells: Potential vs. Reality

In the adult mammal, reserve stem cells, both active and quiescent, serve as primary precursors for differentiated cells. They often provide replacement cells as needed during normal cell homeostasis or serve as residual stem cell sources during periods of stress, trauma or disease. Adult stem cells have a defined level of maturity, accompanied by stability of differentiation, are less likely to invoke an immune response and are often readily derived from reservoirs in bone marrow, blood, adipose tissue and a variety of placental related tissues. While certain adult stem cells are well established as normal cell precursors and used in the treatment of diseases, an expanding array of specific adult stem cells from muscle, heart, nervous tissue, etc. are being discovered and posited as cell progenitors for regenerative therapy. Current preclinical and clinical tests are designed to test the identity, safety, efficacy, and methodology of harvested stem cells or derived cell lines for therapy of specific disorders. Contemporary therapeutic venues, bio-cell, drug and treatment centers have proposed the use of specific adult stem cells for human therapy in regenerative medicine.

Go here to see the original:
Regenerative Medicine Journals | Stem Cell Articles List

Read More...

The Four Frames of Color-Blindness Laura Bestler

July 8th, 2015 6:43 pm

Bonilla-Silva, E. (2006). Color-blind Racism and the Persistence of Racial Inequality in the United States (2nd Ed.). (Ch. 3: The style of color blindness: How to talk nasty about minorities without sounding racist, pp. 53-74)

Abstract Liberalism: involves using ideas associated with political liberalism and economic liberalism in an abstract manner to explain racial matters.

Naturalization: allows whites to explain away racial phenomena by suggesting they are natural occurrences.

Naturalization is a frame that allows whites to explain away racial phenomena by suggesting they are natural occurrences for example whites can claim segregation is natural because people from all backgrounds gravitate toward likeness. Although, the above statements can be interpreted as racist and as contradicting the colorblind logic they are used to reinforce the myth of nonracialism. How? by suggesting these preferences are almost biologically driven and typical of all groups in society, preferences for primary associations with members of ones race are rationalized as nonracial because they (racial minorities) do it too (p. 28).

Cultural Racism: relies on culturally based arguments to explain the standing of minorities in society.

Cultural racism is a frame that relies on culturally based arguments (p. 28)

Minimization of Racism: suggests discrimination is no longer a central factor affecting minorities life choices.

Read more:
The Four Frames of Color-Blindness Laura Bestler

Read More...

Genre Blindness – TV Tropes

July 8th, 2015 6:43 pm

"I can't believe he didn't suspect a trap. See what happens when you don't watch enough television?" A condition afflicting many fictional characters, seen when one demonstrates by their behavior that they have never in their life ever seen the kind of story they're in, and thus have none of the reactions a typical audience member would have in the same situation. Worse, they are unable to learn from any experiences related to their genre. Genre Blindness is what keeps the cast of Threes Company leaping to outrageous conclusions even after the hundredth stupid misunderstanding, instead of sitting down and talking things out. It makes young girls go for walks alone in the woods after midnight without a flashlight or a weapon when there's an axe murderer or a vampire around. It makes the supergenius supervillains in James Bond movies stuff the hero into an elaborate melodramatic Death Trap from which he inevitably escapes instead of just shooting him. Although genre blindness can be a legitimate flaw, it should be noted that it can be difficult for writers to create characters who are not genre blind without hanging a lampshade on it by saying something like "This is just like in the movies!", especially in genres which require suspense that can easily be undone by such comedic relief (such as horrors, thrillers, etc). Furthermore, some stories in some genres really couldn't function at all if the characters displayed an innate and complete understanding of what genre they were in and exactly how they should act at all times within a story in said genre if they want to avoid trouble. A certain amount of Genre Blindness can be required to provide the story with tension and drama, since if the character knows exactly what to do to avoid trouble and conflict in their particular story, they'll do it, and consequently have an easy, trouble-free life, and... why are we watching again? Finally, not all of a genre's classic tropes are in fact Truth in Television, but as far as the characters are concerned, This Is Reality, so their "blindness" may be the same as common sense. For example, in real life, a single cough usually does not herald a fatal disease, so It's Probably Nothing is probably rational despite being Genre Blind. Ultimately, while it can be a problem if used too egregiously, sometimes you just have to shrug your shoulders and chalk it up to Willing Suspension of Disbelief. Related:

open/close all folders

Anime and Manga

Comic Books

Fairy Tales

Fan Fiction

Film-Animated

Film-Live Action

"You best start believing in ghost stories, Miss Turner. You're in one!"

"First, your return to shore was not part of our negotiations nor our agreement so I "must" do nothing. And secondly, you must be a pirate for the pirate's code to apply and you're not. And thirdly, the code is more what you'd call 'guidelines' than actual rules. Welcome aboard the Black Pearl, Miss Turner."

See the rest here:
Genre Blindness - TV Tropes

Read More...

What Is A Stem Cell, Stem Cell Questions, How Do Stem …

July 8th, 2015 6:42 pm

Our Technology

Phoenix Stem Cell Treatment Center uses adipose derived stem cells for deployment & clinical research. Early stem cell research has traditionally been associated with the controversial use of embryonic stem cells. The new focus is on non-embryonic adult mesenchymal stem cells which are found in a persons own blood, bone marrow, and fat. Most stem cell treatment centers in the world are currently using stem cells derived from bone marrow.

A recent technological breakthrough enables us to now use adipose (fat) derived stem cells. Autologous stem cells from a persons own fat are easy to harvest safely under local anesthesia and are abundant in quantities up to 2500 times those seen in bone marrow.

Clinical success and favorable outcomes appear to be related directly to the quantity of stem cells deployed. Once these adipose derived stem cells are administered back in to the patient, they have the potential to repair human tissue by forming new cells of mesenchymal origin, such as cartilage, bone, ligaments, tendons, nerve, fat, muscle, blood vessels, and certain internal organs. Stem cells ability to form cartilage and bone makes them potentially highly effective in the treatment of degenerative orthopedic conditions. Their ability to form new blood vessels and smooth muscle makes them potentially very useful in the treatment of peyronies disease and impotence. Stem cells are used extensively in Europe and Asia to treat these conditions.

We have anecdotal and experimental evidence that stem cell therapy is effective in healing and regeneration. Stem cells seek out damaged tissues in order to repair the body naturally. The literature and internet is full of successful testimonials but we are still awaiting definitive studies demonstrating efficacy of stem cell therapy. Such data may take five or ten years to accumulate. At the Phoenix Stem Cell Treatment Center we are committed to gathering those data by conducting sound and effective clinical research. In an effort to provide relief for patients suffering from certain degenerative diseases that have been resistant to common modalities of treatment, we are initiating pilot studies as experimental tests of treatment effectiveness with very high numbers of adipose derived stem cells obtained from fat. Adipose fat is an abundant and reliable source of stem cells.

Phoenix Stem Cell Treatment Centers cell harvesting and isolation techniques are based on technology from Korea. This new technological breakthrough allows patients to safely receive their own autologous stem cells in extremely large quantities. Our treatments and research are patient funded and we have endeavored successfully to make it affordable. All of our sterile procedures are non-invasive and done under local anesthesia. Patients who are looking for non-surgical alternatives to their degenerative disorders can participate in our trials by filling out our treatment application to determine if they are candidates. Phoenix Stem Cell Treatment Center is proud to be state of the art in the new field of Regenerative Medicine.RETURN TO TOP

We are currently in the process of setting up FDA approved protocols for stem cell banking in collaboration with a reputable cryo-technology company. This enables a person to receive autologous stem cells at any time in the future without having to undergo liposuction which may be inconvenient or contraindicated. Having your own stem cells available for medical immediate use is a valuable medical asset.

Provisions are nearly in place for this option and storage of your own stem cells obtained by liposuction at PSCTC or from fat obtained from cosmetic procedures performed elsewhere should be possible in the near future.RETURN TO TOP

Adult (NonEmbryonic) Mesenchymal Stem Cells are undifferentiated cells that have the ability to replace dying cells and regenerate damaged tissue. These special cells seek out areas of injury, disease and destruction where they are capable of regenerating healthy cells and enabling a persons natural healing processes to be accelerated. As we gain a deeper understanding of their medical function and apply this knowledge, we are realizing their enormous therapeutic potential to help the body heal itself. Adult stem cells have been used for a variety of medical treatments to repair and regenerate acute and chronicially damaged tissues in humans and animals. The use of stem cells is not FDA approved for the treatment of any specific disease in the United States at this time and their use is therefore investigational. Many reputable international centers have been using stem cell therapy to treat various chronic degenerative conditions as diverse as severe neurologic diseases, renal failure, erectile dysfunction, degenerative orthopedic problems, and even cardiac and pulmonary diseases to name a few. Adult stem cells appear to be particularly effective at repairing cartilage in degenerated joints.RETURN TO TOP

Regenerative Medicine is the process of creating living, functional tissues to repair or replace tissue or organ function lost due to damage, or congenital defects. This field holds the promise of regenerating damaged tissues and organs in the body by stimulating previously irreparable organs to heal themselves. (Wikipedia)RETURN TO TOP

See more here:
What Is A Stem Cell, Stem Cell Questions, How Do Stem ...

Read More...

Preventive Medicine – Miami Children’s Hospital

July 7th, 2015 8:45 pm

Division of Community Pediatrics and Preventive Medicine

Mission and Vision

Mission: To provide early, accessible preventive and interventional health services to improve the health status of children and adolescents in South Florida by early identification of risk factors that affect their health through the implementation of clinical, educational and research programs.

Vision: Nicklaus Children's Hospital, formerly Miami Children's Hospital, will be recognized as a national leader in disease prevention, health policy/advocacy and health promotion efforts by addressing the health needs of children and adolescents. This vision will be driven by ongoing monitoring, assessment leading to policy-making oriented towards the prevention of diseases and related risk factors, therefore improving morbidity and mortality rates

School-Based Programs

The Nicklaus Children's Hospital, formerly Miami Children's Hospital, Division of Community Pediatrics and Preventive Medicine is partnering with The Childrens Trust of Miami-Dade County to offer school-based health clinics, as part of the Health Connect in Our Schools Program.

This initiative, which provides a nurse practitioner and licensed practical nurse (LPN) at high-risk schools, provides preventive and basic school health services in an effort to decrease absenteeism and improve health outcomes of the student population. The program also seeks to assign medical homes for children without a pediatrician.

For more information on this program, please call 305-663-6800.

See the original post here:
Preventive Medicine - Miami Children's Hospital

Read More...

Genetic Medicine : Division Home | Department of Medicine

July 7th, 2015 8:43 pm

Advances in molecular biology and human genetics, coupled with the completion of the Human Genome Project and the increasing power of quantitative genetics to identify disease susceptibility genes, are contributing to a revolution in the practice of medicine. In the 21st century, practicing physicians will focus more on defining genetically determined disease susceptibility in individual patients. This strategy will be used to prevent, modify, and treat a wide array of common disorders that have unique heritable risk factors such as hypertension, obesity, diabetes, arthrosclerosis, and cancer.

The Division of Genetic Medicine provides an academic environment enabling researchers to explore new relationships between disease susceptibility and human genetics. The Division of Genetic Medicine was established to host both research and clinical research programs focused on the genetic basis of health and disease. Equipped with state-of-the-art research tools and facilities, our faculty members are advancing knowledge of the common genetic determinants of cancer, congenital neuropathies, and heart disease. The Division faculty work jointly with the Vanderbilt-Ingram Cancer Center to support the Hereditary Cancer Clinic for treating patients and families who have an inherited predisposition to various malignancies.

View post:
Genetic Medicine : Division Home | Department of Medicine

Read More...

Functional Endocrinology Of Ohio – Natural Alternative …

July 6th, 2015 11:43 am

Welcome to Functional Endocrinology of Ohio

To give Hope to those who lost it, Healing to those who need it,and Inspiration to those who seek it to restore people to their God-given health potential is what we do.

For more information or to schedule an appointment in either our Akron or Independence office, click on the blue button above orcall (330) 644-5488 (Akron)or (216) 236-0060(Independence) today! Also, be sure to read about and sign up forour Exclusive Offer below and subscribe to one of our email/video newsletters by clicking on the Newsletter buttonabove. We also offer free workshops and classes. Click on the calendar tab above to check out the schedule and then call or email us to register. You can also view the full 2013 class schedule by clicking here.

Functional Endocrinology of Ohio is a functional, naturalmedicine and chiropractic practice devoted to maintaining the lifetime health and wellness of our clients from a metabolic, neurologic, and structural standpoint. Whether you are suffering from a particular health condition (like diabetes, thyroid, autoimmune, fibromyalgia, MTHFR, etc.) or fromback pain, neck pain, knee pain, neuropathy, headaches, or even just plain old muscular tightness and tension, we can help - naturally!See our full list of conditions treated by clicking on the "Conditions Treated" tab above.

When you come to our office,Functional Endocrinology of Ohio,we will explain the science behind how functional medicine, in conjunction with chiropractic care (in some cases), works to help you with all of your health issues. We will then conduct a full exam and case history to see if our treatment protocols are right for you.If there is a good fit, we willdevelop a treatment plan that is CUSTOMIZED toYOUR condition and health goals.

Ifyou want to find out more, please email us or call (330) 644-5488 or (216) 236-0060 to learn more fromour friendly team. We also welcome referrals, so feel free to use the "Send to a Friend" link located at the bottom of every page to share our health information with your friends and loved ones.

If you would like to stay informed about cutting edge health and wellness issues and treatments,or if you want to start receiving free articles about health and wellness news, please subscribe to ournewsletter, even if you are not a client. Once you are subscribed, you will be receive articles,videos and other resources directly in your email in-box so that you can learn more.

Dr. Keith S. Ungar,Dr. David Starkey, Dr. Andrew Kender

Akron and Cleveland Chiropractic Physicians

Originally posted here:
Functional Endocrinology Of Ohio - Natural Alternative ...

Read More...

Genetic determinants of exceptional human longevity …

July 6th, 2015 9:45 am

Age (Dordr). 2006 Dec; 28(4): 313332.

1College of Nursing, Okinawa Prefectural University, 1-24-1 Yogi, Naha City, Okinawa Japan 902-0076

2Pacific Health Research Institute, 846 South Hotel Street, Suite 301, Honolulu, HI 96813 USA

3Departments of Geriatric Medicine and Medicine, John A. Burns School of Medicine, University of Hawaii, 1356 Lusitana Street, 7F, Honolulu, HI 96813 USA

4School of Medicine, University of California San Francisco, 74 New Montgomery Street, Suite 600, San Francisco, CA 94105 USA

52200 Post Street, C433, San Francisco, CA 94143-1640 USA

6Faculty of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa, Japan

Received 2006 Jun 6; Revised 2006 Sep 30; Accepted 2006 Oct 1.

Centenarians represent a rare phenotype appearing in roughly 1020 per 100,000 persons in most industrialized countries but as high as 4050 per 100,000 persons in Okinawa, Japan. Siblings of centenarians in Okinawa have been found to have cumulative survival advantages such that female centenarian siblings have a 2.58-fold likelihood and male siblings a 5.43-fold likelihood (versus their birth cohorts) of reaching the age of 90years. This is indicative of a strong familial component to longevity. Centenarians may live such extraordinarily long lives in large part due to genetic variations that either affect the rate of aging and/or have genes that result in decreased susceptibility to age-associated diseases. Some of the most promising candidate genes appear to be those involved in regulatory pathways such as insulin signaling, immunoinflammatory response, stress resistance or cardiovascular function. Although gene variants with large beneficial effects have been suggested to exist, only APOE, an important regulator of lipoproteins has been consistently associated with a longer human lifespan across numerous populations. As longevity is a very complex trait, several issues challenge our ability to identify its genetic influences, such as control for environmental confounders across time, the lack of precise phenotypes of aging and longevity, statistical power, study design and availability of appropriate study populations. Genetic studies on the Okinawan population suggest that Okinawans are a genetically distinct group that has several characteristics of a founder population, including less genetic diversity, and clustering of specific gene variants, some of which may be related to longevity. Further work on this population and other genetic isolates would be of significant interest to the genetics of human longevity.

Key words: longevity, genetics, centenarians, Okinawa, longevity genes

Read the original:
Genetic determinants of exceptional human longevity ...

Read More...

Overview | Institute for Aging Research | Albert Einstein …

July 6th, 2015 9:45 am

The Institute for Aging Research conducts focused multidisciplinary investigations to unravel essential elements in the biology of aging.

The New York Times and NPR feature Nir Barzilai, M.D., and one of his centenarian study participants in a joint article on aging. (November 19, 2014)

The New York Times profiles Nir Barzilai, M.D. (September 27, 2014)

Wall Street Journal features new research by Nir Barzilai, M.D. that found lower levels of growth hormone are associated with extended lifespan in centenarians. (March 25, 2014)

The Scientist features Ana Maria Cuervo's discovery of how cells selectively break down their waste, and the health consequences that arise when that process malfunctions. (November 1, 2013)

Scientific American interviews Nir Barzilai, M.D., about latest research advances for slowing or delaying the aging process in humans. Dr. Barzilai, who conducts longevity research with centenarians, notes his superagers tend to have a significant delay in the onset of age-related diseases and stay healthier longer. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research at Einstein and attending physician at Montefiore Medical Center.

Nature features Nir Barzilai, M.D., and his proposed TAME study, which will investigate if the widely used diabetes drug metformin can delay aging. Dr. Barzilai notes that he and his colleagues are not seeking the fountain of youth, but rather an effective means to extend the number of healthy years an individual has, or healthspan. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research at Einstein and attending physician at Montefiore Medical Center.

The Scientist interviews Nir Barzilai, M.D., and Evris Gavathiotis, Ph.D., about their success in pursuing private funding in the face of federal funding cuts. Drs. Barzilai and Gavathiotis share how they identified and pursued alternative funding sources and how it has helped advance their research. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research at Einstein and attending physician at Montefiore Medical Center. Dr. Gavathiotis is assistant professor of biochemistry and of medicine.

The New York Timesreferences Einsteins centenarian studies and Nir Barzilai, M.D., in an obituary on 109-year old Irving Kahn. Kahn, considered the oldest active Wall Street investor before his death, was a participant in Dr. Barzilais studies at EinsteinsInstitute of Aging Research. He was also profiled as part of EinsteinsLongevity Genes Project video series. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research at Einstein and attending physician at Montefiore Medical Center.

Visit link:
Overview | Institute for Aging Research | Albert Einstein ...

Read More...

Genetic Improvement of Dairy Cow Longevity – eXtension

July 6th, 2015 9:45 am

Annual herd turnover rates and reported reasons for culling may be misleading, and the timing of culling during the lactation can be a more useful indicator of potential management problems on a given farm. Conformation traits are often used to select for improved cow longevity, but these traits account for only a modest proportion of differences in cow survival. Significant genetic variation exists between sires in the length of productive life of their daughters, as well as susceptibility to specific health disorders. Genetic improvement of cow survival should focus on direct measures of longevity, fertility, and health.

Dairy cow survival is influenced by many factors. Non-genetic factors include stall size, bedding type, degree of overcrowding, heat abatement devices, nutrition, veterinary care, herd expansion plans, milk quota restrictions, and availability and affordability of replacement heifers. As shown below, genetic improvement of longevity involves breeding animals that can produce a live calf without assistance; cycle normally, show visible heat, and conceive when inseminated; maintain adequate body condition and resist metabolic disorders; avoid udder injuries and fight off infection by mastitis pathogens; walk and stand comfortably without frequent hoof trimming, and efficiently produce milk of desirable composition. Many cows fail to complete these tasks and leave the herd prematurely. In some cases, the cow is genetically flawed, while in other cases her environment is lacking. Significant genetic variation exists between sire families for longevity, fertility, calving performance, and disease resistance. Therefore, we can improve longevity directly by selecting families that resist culling, or we can improve longevity indirectly by selecting families that excel for each of its component traits.

Please check this link first if you are interested in organic or specialty dairy production

Much negative attention has been given to the annual turnover or replacement rates on commercial dairy farms. However, the overall replacement rate for a given herd doesnt provide enough information to indicate whether or not a problem exists; one needs to know which cows left the herd, as well as the reasons for and timing of their removal. Suppose that 35% of the milking cows in each of two dairies were replaced last year. In one herd, the majority of these were low-producing, older animals that were culled late in lactation and subsequently replaced by younger, genetically superior heifers grown from within the operation. In the other herd, the majority were young, high-producing cows that were culled or died early in lactation due to calving problems, mastitis, lameness, ketosis, and other metabolic disorders, and the owner was forced to buy springing heifers from a cattle dealer at the prevailing market price. Thus, even though the replacement rates on these farms are identical, ones interpretation of each herd's management success is vastly different. Replacement rates can also be misleading in herds that have an excess of replacement heifers. Suppose one herd sells its extra animals as springing heifers prior to first calving, while another herd calves all of its heifers and culls stringently for low production within the milking herd. Both may be successful in terms of managing the health, fertility, and productivity of their cattle, but the former will have a substantially lower annual replacement rate. In general, herds with lower replacement or turnover rates tend to be more successful in terms of cow comfort, health, and productivity. However, replacement rates can be misleading, and more detailed information about the reasons for culling and the timing of culling is needed. Furthermore, herd turnover rates are influenced heavily by external factors, such as expansion plans and replacement heifer prices.

Dairy producers routinely report reasons for disposal as part of the national milk recording program. Animals can be recorded as died, sold for dairy, or sold for beef, with the latter category broken down into low production, mastitis, infertility, and so on. These descriptive reasons for disposal can be useful when studying the general demographics of a national dairy herd. For example, one might use such data to conclude that mastitis and infertility are the most common causes of culling on most dairy farms. However, reported reasons for disposal can be misleading when one attempts to compare the management level of various dairy farms, or when one attempts to draw conclusions about the genetic merit of certain animals or sire families. Many animals are culled for multiple offenses. For example, a cow might have a difficult calving, followed by a case of ketosis, and a displaced abomasum. She may then fail to breed back in a timely manner and be culled from the herd when her daily milk production drops below a profitable level. The farmer might code her as sold for low production, sold for infertility, or sold due to disease. Thus, the reported reason for disposal is often a vague indicator of the actual problem. Furthermore, inconsistencies may exist between reported reasons for disposal and the actual health and reproductive history of the culled animals.

Stewart (Steve Stewart, Univ. of Minnesota, 2002, unpublished) proposed the idea of using the timing of culling within the lactation as an indirect indicator of the reason for disposal. He constructed a graph showing the proportion of total culled animals that were removed within certain time periods during the lactation. An example of this type of graph is shown below, where the percentage of culled cows that left during each 3-week period from calving to 440 d postpartum is shown for 59,390 cows that calved in 2001-2003 and were subsequently culled from 151 herds that participate in the Alta Genetics (Watertown, WI) Advantage Progeny Testing Program. One can hypothesize that cows that were culled between 0 and 62 d postpartum may have left due to calving problems or early lactation metabolic disorders, while cows that were culled between 63 and 293 d postpartum may have left due to mastitis or lameness, and cows that were culled after 294 d postpartum may have left due to infertility. Exceptions to the rule exist, as a cow that is culled today may actually reflect the outcome of a do not breed decision that occurred many months earlier. Nonetheless, an analysis of the timing of culling events within a dairy herd may provide a more objective description of management on a given farm than one can obtain by inspecting the overall turnover rate or reported reasons for disposal. Furthermore, genetic evaluation of dairy sires based on the proportion of daughters that were culled during each period of the lactation may provide a useful indicator of differences in susceptibility to various diseases or disorders. For example, one could compute sire predicted transmitting abilities for early lactation survival, and this might identify bulls whose daughters avoid calving complications and resist early postpartum metabolic disorders.

Initial attempts to improve dairy cow longevity through artificial selection began in the 1970s and early 1980s when breed associations and AI studs first developed linear type appraisal programs. For the next two decades, type and longevity were considered as synonymous. Bulls that sired daughters with high, wide rear udders, strong median suspensory ligaments, well-attached fore udders, and correct teat placement were considered to transmit superior longevity. Likewise, bulls that sired daughters with strong pasterns, a steep foot angle, and correct set to the hock were expected to improve longevity.

Numerous studies have addressed the genetic relationships between linear type traits and longevity (e.g., Caraviello et al., 2004a; Sewalem et al, 2004; Short and Lawlor, 1992). Early studies relied on the estimation of genetic correlations between longevity and linear type traits, and these studies typically invoked a 60-, 72-, or 84-month opportunity period for longevity. However, these studies suffered from two major limitations. First, the use of genetic correlation parameters to assess trait-longevity relationships limited these studies to measurement of linear relationships only. Few traits have a strictly linear relationship with longevity, and the role of traits with intermediate optima or traits that offer diminishing returns as scores increase cannot be evaluated properly using genetic correlations. Second, the use of a long opportunity period, to allow each cow to fully express her genetic potential for longevity, resulted in a tremendous time lag between the birth of animals in the study group and eventual publication of results. For example, the youngest cows in the Short and Lawlor (1992) study were born in 1982, so more than a decade of additional genetic and management improvements occurred prior to publication of results of the study. The use of survival analysis methodology in more recent studies (e.g., Caraviello et al., 2004b) alleviated several of the aforementioned limitations. In many of these studies, linear type scores were grouped into categories, and no restrictions were placed on the form of the trait-longevity relationship. Furthermore, because survival analysis allows proper modeling of censored records from animals that are still alive (Ducrocq, 1994), these studies used much more timely data than previous studies that invoked a long opportunity period. Results indicated that many type traits, such as rear leg set, rump angle, or dairy form, have intermediate optima, while many others, such as udder support, teat placement, or foot angle, seem to display a pattern of diminishing returns. More importantly, these studies demonstrated that udder depth, fore udder attachment, rear udder attachment, and udder support were of primary importance with respect to longevity, while rear leg set and foot angle were of secondary importance, and stature had no importance. Despite the importance of physical conformation, a significant proportion of the genetic variation in longevity remained unexplained by existing type or production traits well into the 1990s. Numerous examples were noted of bulls that transmitted outstanding production and type to their daughters but whose daughters nonetheless tended to leave the herd prematurely. Thus, type traits can be used as an indirect indicator of the expected longevity of a bull's daughters, and actual culling and fertility data are needed to explain the rest of the story.

In 1994, the USDA Animal Improvement Programs Laboratory (Beltsville, MD) introduced national genetic evaluations for length of productive life (PL), which was measured as the total number of months in milk from first calving until 84 mo of age, with a limit of 10 mo per lactation (VanRaden and Klaaskate, 1993). Because the vast majority of cows are culled by 84 mo of age, this seems to provide a reasonable opportunity period. In fact, the additional gain in accuracy that could be achieved by waiting for a few, highly selected daughters to complete 8, 10, or 12 yr of PL would be negligible. Because the starting point of the opportunity period (date of first calving) can vary, it is possible that this definition of PL may favor animals that calve at a young age. However, the phenotypic variation in age at first calving on most commercial dairies is rather limited. The limit of 10 mo of PL per lactation was applied for two reasons: because it seemed desirable to penalize cows that have a long dry period and an extended calving interval and because test-day production data beyond 305 d postpartum were unavailable historically. However, this restriction may have some unintended consequences, in terms of the genetic relationships between PL and other traits in the breeding goal. Tsuruta et al. (2005) showed that the genetic correlation between milk yield and PL changed from -0.11 with a 305 d limit, to +0.08 with a 500 d limit, and to +0.14 with a 999 d limit. Corresponding genetic correlations between days open and PL were -0.62, -0.36, and -0.27 for per lactation PL limits of 305 d, 500 d, and 999 d, respectively, while genetic correlations with dairy form were -0.25, -0.12, and -0.08, respectively. An extension of the current 305 d limit to a value that is more closely aligned with the management of modern commercial dairies, such as 365 d or 400 d, has been discussed. An additional argument for extending, or even removing, a limit on PL credits per lactation is that national dairy sire evaluations for daughter pregnancy rate (DPR) are now routinely available, and indirect selection for fertility using PL information is no longer necessary. An important aspect of current national genetic evaluations for PL is that records of cows that are still alive can be extended or projected to obtain an estimate of the total months in milk that such animals will accumulate by culling or 84 mo of age (VanRaden and Klaaskate, 1993). Thus, the 84-mo opportunity period does not cause a major delay or time lag in computing sire PTA for PL. On the other hand, the accuracy of such projections is low much lower than the accuracy of projected 305 d milk production records based on the first two or three test-day yields.

The primary concern with regard to genetic evaluation of PL is the substantial period of time required to obtain complete culling data for daughters of a given bull. Because a short generation interval is desirable in genetic selection programs, AI studs and pedigree breeders like to make sire selection decisions as quickly as possible. However, when a recently tested sire is being considered as a sire of sons or as an embryo transfer sire, most of his daughters are still alive. Therefore, reliability of PL evaluations is often low at the most critical points in life. This can lead to errors in selection decisions, particularly for bulls whose daughters fail to follow a typical maturity pattern. If a particular bull's daughters mature more or less gracefully than daughters of an average bull, his PTA can change significantly over time. Weigel et al. (1998) developed a procedure by which correlated traits, such as type, production, and somatic cell score, can be used to compute an indirect prediction of a bulls PTA for PL. The indirect prediction for a given bull can then be combined with his direct prediction, which is based on actual culling data, using weights that depend on the REL of direct and indirect predictions. The combined PTA will have higher REL than either the direct or indirect prediction, especially early in life. Although the combined PL predictions tend to be more accurate than direct predictions for the majority of sires, there are exceptions. The most disturbing cases are bulls whose daughters appear promising in first lactation but mature less gracefully than daughters of an average bull. These bulls tend to have a high indirect prediction early in life, but their combined PTA tends to decrease over time, as daughters mature and get culled from the herd more rapidly than anticipated.

Here is the original post:
Genetic Improvement of Dairy Cow Longevity - eXtension

Read More...

Steamed Longevity Peach-shaped Buns | Marishia’s …

July 6th, 2015 9:44 am

The Longevity Bun is similar to pau/bao but with a unique shape of a peach. The bun is airbrushed with a reddish/pinkish colorful top. You can make them in single bun or double (join 2 buns together to get a 3D image of a peach. It is stuffed with red bean paste or lotus paste or custard. It is available in the marketplace or Chinese pastry bakery or restaurants (for special occasionslike birthday or birth) too but not that popular.

Also the longevity buns are used for ritual events (Birthdays of Goddess, God or Saints) to offer their prayers. These Longevity buns are made to symbolize those immortality and magical peaches. It also symbolizes a collective aspiration and reflects traditional values that respect the elderly.

It is a challenge for me because I try many times but could not get the right shape and texture. After a few attempts, I managed to come out with this recipe and turn out well in time for the Chinese New Year celebration and be able to share with you all. What a long journey for me on working this piece of work.

Makes 20-22 buns

Ingredients:

Dough:

2 cups All Purpose flour

Read more:
Steamed Longevity Peach-shaped Buns | Marishia's ...

Read More...

Life Extension Information, Research and Products

July 6th, 2015 9:44 am

Summary: If you want to live longer and stay healthy your chances are better if you substantially reduce or eliminate sugar-sweetened beverages from your diet.

Consumption of sugary drinks may lead to an estimated 184,000 adult deaths each year worldwide, according to research published today in the journal Circulation and previously presented as an abstract at the American Heart Association Council on Epidemiology and Prevention in 2013.

Many countries in the world have a significant number of deaths occurring from a single dietary factor, sugar-sweetened beverages. It should be a global priority to substantially reduce or eliminate sugar-sweetened beverages from the diet, said Dariush Mozaffarian, M.D., Dr.P.H., senior author of the study and dean of the Friedman School of Nutrition Science & Policy at Tufts University in Boston.

In the first detailed global report on the impact of sugar-sweetened beverages, researchers estimated deaths and disabilities from diabetes, heart disease, and cancers in 2010. In this analysis, sugar sweetened beverages were defined as any sugar-sweetened sodas, fruit drinks, sports/energy drinks, sweetened iced teas, or homemade sugary drinks such as frescas, that contained at least 50 kcal per 8oz serving. 100 percent fruit juice was excluded.

Estimates of consumption were made from 62 dietary surveys including 611,971 individuals conducted between 1980 and 2010 across 51 countries, along with data on national availability of sugar in 187 countries and other information. This allowed capture of geographical, gender and age variation in consumption levels of sugar-sweetened beverages in different populations. Based on meta-analyses of other published evidence on health harms of sugar-sweetened beverages, the investigators calculated the direct impact on diabetes and the obesity-related effects on cardiovascular disease, diabetes and cancer.

In 2010, the researchers estimate that sugar-sweetened beverages consumption may have been responsible for approximately:

133,000 deaths from diabetes

45,000 deaths from cardiovascular disease

6,450 deaths from cancer

Some population dietary changes, such as increasing fruits and vegetables, can be challenging due to agriculture, costs, storage, and other complexities. This is not complicated. There are no health benefits from sugar-sweetened beverages, and the potential impact of reducing consumption is saving tens of thousands of deaths each year, Mozaffarian said.

Link:
Life Extension Information, Research and Products

Read More...

Page 1,190«..1020..1,1891,1901,1911,192..1,2001,210..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick